This report provides the evidence base for why a CAR T Vision is needed, the challenges that it looks to solve, and the urgent action required to achieve it. It is a call to action for all stakeholders to unite with a single purpose to overcome the barriers that prevent eligible patients from having the opportunity for cure.

This is just the beginning.

We call on patient and caregiver organizations, HCPs, payors, HTA bodies, regulators, policymakers, legislators, and industry, to review this report and consider how you can contribute to joint efforts to ensure more eligible patients get access to CAR T-cell therapy in the next five years.

Building on this report, expert Working Groups will translate the Vision into local, measurable action, with measurement frameworks to track progress. Each Working Group will consist of Steering Committee members as well as additional ecosystem stakeholders and experts.

Logo of CAR T Vision

It’s Time for CAR T